Strategies and Applications of Antigen-Binding Fragment (Fab) Production in Escherichia coli
With the advancement of genetic engineering, monoclonal antibodies (mAbs) have made far-reaching progress in the treatment of various human diseases. However, due to the high cost of production, the increasing demands for antibody-based therapies have not been fully met. Currently, mAb-derived alter...
I tiakina i:
| Ngā kaituhi matua: | , , , , , , |
|---|---|
| Hōputu: | Artigo |
| Reo: | Inglês |
| I whakaputaina: |
Georg Thieme Verlag KG
2021-06-01
|
| Rangatū: | Pharmaceutical Fronts |
| Ngā marau: | |
| Urunga tuihono: | http://www.thieme-connect.de/DOI/DOI?10.1055/s-0041-1735145 |
| Ngā Tūtohu: |
Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!
|